Log inSign up
user avatar
BrainStorm
@BrainstormCell
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage biotechnology company developing autologous cell therapies for neurodegenerative diseases.
New York, New York
brainstorm-cell.com
Joined September 2012
762
Following
5,076
Followers
  • Pinned
    user avatar
    BrainStorm
    @BrainstormCell
    May 28
    We are honored to welcome @PeterPitts, former @US_FDA Associate Commissioner, to BrainStorm's Board of Directors. His expertise will help support our mission to advance NurOwn® for people living with ALS. #NurOwn #Biotech #FDA #ALS Read more: bit.ly/4uD6Q0o
    930
  • user avatar
    BrainStorm
    @BrainstormCell
    Aug 15, 2022
    Today, we are pleased to share an important development in our efforts to deliver hope for those living with #ALS. We owe it to them to do everything in our power to provide access to promising therapies as quickly as possible because they don’t have time to wait. 🧵
  • user avatar
    BrainStorm
    @BrainstormCell
    Aug 15, 2022
    Replying to @BrainstormCell
    After carefully considering these learnings, the totality of the evidence from NurOwn’s clinical studies, and the feedback received from key opinion leaders and the broader ALS community, we will submit a Biologics License Application to @US_FDA.
  • user avatar
    BrainStorm
    @BrainstormCell
    Aug 15, 2022
    Replying to @BrainstormCell
    A special thanks is reserved for all the clinical trial participants and their loved ones. Their sacrifices and contributions are advancing science and giving hope for a more promising future.
  • user avatar
    BrainStorm
    @BrainstormCell
    Dec 23, 2021
    President Biden signed #ACTforALS into law. We are thrilled to celebrate this enormous step forward. Congratulations to those waging the fight against #ALS for making today possible. We look forward to swift implementation as we continue working to deliver new treatments. #ENDALS
  • user avatar
    BrainStorm
    @BrainstormCell
    Dec 13, 2021
    We are excited to share that @MuscleAndNerve just published the peer reviewed clinical data for the phase 3 study of #NurOwn for ALS, with the totality of evidence showing the potential for NurOwn to be a successful treatment.
    ir.brainstorm-cell.com
    BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Study for ALS...
    BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the peer reviewed publication of Phase 3 clinical data...
  • user avatar
    BrainStorm
    @BrainstormCell
    Aug 30, 2022
    We are deeply saddened by the news that @sandymorris333 has passed away. Sandy fought #ALS with heart, strength, and courage. Along the way she helped to build a movement that will conquer this devastating disease.
  • user avatar
    BrainStorm
    @BrainstormCell
    Dec 2, 2020
    We are proud to share this new video illustrating how #NurOwn is thought to work in patients. As more data from our Phase 3 clinical trial is shared, we are also building understanding of why NurOwn is a promising investigational treatment option.
  • user avatar
    BrainStorm
    @BrainstormCell
    Apr 27, 2022
    “No one would argue that ALS sucks but very few people, even caregivers, really understand what facing ALS means on a daily basis,” says @Sunnystrongals. The #FightALSFilmFest aims to make it clear those impacted by #ALS are not alone. Register here: bit.ly/3v2SKcl
  • user avatar
    BrainStorm
    @BrainstormCell
    May 3, 2022
    On May 9, join #FightALSFilmFest to discuss VICE: Die Trying. Battling #ALS herself, #VICE editor @NotSoVanilla meets with patients and top researchers to find out what's being done to tackle this devastating disease. To register for the event: bit.ly/3v2SKcl
  • user avatar
    BrainStorm
    @BrainstormCell
    Dec 17, 2021
    We join the entire #ALS community in celebrating yesterday’s passage of #ACTforALS. This is a monumental victory for patients living with ALS by creating new pathways to deliver treatments that could help them. #NeverGiveUp
  • user avatar
    BrainStorm
    @BrainstormCell
    Aug 15, 2022
    Replying to @BrainstormCell
    The continued analysis and the feedback received from the many scientific presentations of the Phase 3 data uncovered key insights that furthered our understanding of NurOwn's mechanism of action and potential as a treatment for ALS.
  • user avatar
    BrainStorm
    @BrainstormCell
    May 5, 2021
    BrainStorm is proud to share that we have submitted a manuscript from our Phase 3 clinical trial in ALS to a peer-reviewed journal. Publication timing depends on the journal’s review process $BCLI #ENDALS
  • user avatar
    BrainStorm
    @BrainstormCell
    Apr 26, 2022
    YOU ARE INVITED:This May #ALSawarenessMonth, please join us in participating in the #FightALSFilmFest, where each week you will have the opportunity to view a film and join a conversation about the realities of #ALS. Register here for the month-long event: bit.ly/3v2SKcl